Breaking News

inVentiv Health Opens New Clinic in Miami

January 13, 2016

Extends Phase I services to the U.S.

inVentiv Health has opened its new Phase I clinic in the U.S., located at the University of Miami Life Science and Technology Park.

The services provided at this facility will complement the Phase I through Phase IV clinical capabilities offered at the company's existing bioanalytical labs.

"The Miami clinic is purpose-built to optimize trials for clients from the start," said Michael McKelvey, president, inVentiv Health Clinical Division and executive vice president, inVentiv Health. "Everything from the location, to the pioneering processes we will use to enroll patients, to the ability to inject market access knowledge into the design strategy from the earliest phases of development, is intended to help clients improve trial execution, speed time to market and reduce development costs."

The Miami clinic will facilitate patient, special populations and normal healthy volunteer access to research for clients focused on complex studies, including first-in-human Phase I, Phase I-in-patient and other multifaceted Phase I trials such as drug-drug interaction, biosimilar, first-to-file and 505b2 trials.

Related Contract Manufacturing:

blog comments powered by Disqus
  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research